PISCATAWAY, N.J, April 1, 2020 /PRNewswire/ -- GenScript, a world leading biotechnology company, today announced the commercial launch of its neoantigen peptide synthesis service for biotech and ...

GenScript now offers fast-track cGMP neoantigen peptide and peptide active pharmaceutical ingredients (API) from its new life-sciences manufacturing facility in Zhenjiang, leveraging its long history ...

GenScript's new life-science building in Zhenjiang, Jiangsu, China spans 91,310 sq. ft. and is ISO 9001 certified; highly automated clean-room facilities offer fast-turnaround, high-purity ...

In prominent research fields such as immunotherapy, vaccine development, drug discovery, and proteomics, target screening is frequently carried out using peptide libraries, which are systematic ...

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager ...

What are the challenges with developing neoantigen-based precision therapeutics and how can they be solved? Samantha Zaroff, Senior Technical Writer at GenScript (NJ, USA), discusses. What challenges ...